しかし、ここで注目したいのは、ジェネリックとの価格差が（ほとんど）なくなっても人気を保ち続けている先発薬が存在 ...

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former Sanofi unit at about €5 billion ($5.4 billion), according to people ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

Attorney General Keith Ellison celebrates settlements with two drug companies he accused of “scheming” to raise prices on ...

National settlements with two generic drug companies over allegedly massive price-fixing conspiracies could be the first of ...

Some section of analysts believe that if Trump enforces additional tariffs on Chinese imports, India could benefit from the ...

Two drug companies will pay a combined $49.1 million for their alleged involvement in schemes to inflate drug prices and limit competition in the generic pharmaceuticals market nationwide, the ...

These substantial financial requirements are compelling pharmaceutical companies to outsource their manufacturing needs to Contract Development and Manufacturing Organizations (CDMOs), which ...

Teva Pharmaceutical Industries Limited (NYSE ... As you can see from this slide, what I'm pleased about in this slide is the ...

The settlement is part of ongoing litigation by a multistate coalition, led by the Connecticut Attorney General, related to allegations of generic drug price-fixing. The multistate coalition has filed ...

The "Pharmaceutical Contract Manufacturing Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Pharmaceutical Contract Manufacturing Market is set to ...